Marshall Wace, LLP Fortress Biotech, Inc. Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.8 - $1.5 $56,587 - $106,101	-70,734 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.24 - $2.75 $72,640 - $161,097	58,581 Added 482.03%	70,734 $95,000
Q4 2021 Feb 14, 2022	BUY	$2.42 - $3.65 $29,410 - $44,358	12,153 New	12,153 $30,000
Q1 2020 May 15, 2020	SELL	$1.14 - $2.96 $25,315 - $65,732	-22,207 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.25 - $2.57 $29,506 - $60,664	-23,605 Reduced 51.53%	22,207 $57,000
Q3 2019 Nov 14, 2019	BUY	$1.26 - $1.96 $57,723 - $89,791	45,812 New	45,812 $65,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $189M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.